Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Potent inhibitors of HIV-1 and other enveloped viruses reported

April 30, 1997

Vertex designs potent, conformationally restricted HIV protease inhibitors

April 30, 1997

Preclinical studies with GPI-2A reported by Genesys Pharma

April 30, 1997

ISIS-5320: preclinical study results

April 30, 1997

Didox/Trimidox demonstrate antiretroviral activity in murine model

April 30, 1997

Joint venture created to develop calanolide A as anti-HIV treatment

April 29, 1997

Target of action of AR-177 elucidated

April 29, 1997

DuPont Merck describes potent, orally bioavailable cyclic urea HIV protease inhibitor

April 29, 1997

Pharmacokinetic data for pentafuside in rodents, monkeys and man

April 29, 1997

Potent, metabolically stable cyclic urea HIV protease inhibitors under development at DuPont Merck

April 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...